703894008: Empagliflozin (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with cellular transport inhibitor mechanism of action (substance)\Sodium glucose cotransporter subtype 2 inhibitor\Empagliflozin

\Substance categorised by structure\Chemical\Chemical categorized by structure\Organic compound\Substance with ether structure (substance)\Empagliflozin

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2015. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Empagliflozin	Is a	Sodium glucose cotransporter subtype 2 inhibitor	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Empagliflozin	Has disposition	Sodium glucose cotransporter subtype 2 inhibitor (disposition)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Empagliflozin	Is a	Substance with ether structure (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Empagliflozin 10 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Empagliflozin	Inferred relationship	Existential restriction modifier (core metadata concept)
Empagliflozin 25 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Empagliflozin	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing empagliflozin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Empagliflozin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing empagliflozin and linagliptin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Empagliflozin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Empagliflozin- and metformin-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Empagliflozin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Empagliflozin 10 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Empagliflozin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Empagliflozin 10 mg oral tablet	Has basis of strength substance (attribute)	True	Empagliflozin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Empagliflozin 25 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Empagliflozin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Empagliflozin 25 mg oral tablet	Has basis of strength substance (attribute)	True	Empagliflozin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Empagliflozin 10 mg oral tablet	Has precise active ingredient	True	Empagliflozin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Empagliflozin 25 mg oral tablet	Has precise active ingredient	True	Empagliflozin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing empagliflozin in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Empagliflozin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only empagliflozin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Empagliflozin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Empagliflozin and linagliptin only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Empagliflozin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing only empagliflozin and metformin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Empagliflozin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing only empagliflozin in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Empagliflozin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Empagliflozin 12.5 mg and metformin hydrochloride 850 mg oral tablet	Has precise active ingredient	True	Empagliflozin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Empagliflozin 12.5 mg and metformin hydrochloride 850 mg oral tablet	Has basis of strength substance (attribute)	True	Empagliflozin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing only empagliflozin and metformin in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Empagliflozin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Empagliflozin 5 mg and metformin hydrochloride 850 mg oral tablet	Has precise active ingredient	True	Empagliflozin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Empagliflozin 5 mg and metformin hydrochloride 850 mg oral tablet	Has basis of strength substance (attribute)	True	Empagliflozin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely empagliflozin 12.5 milligram and metformin hydrochloride 1 gram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Empagliflozin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely empagliflozin 12.5 milligram and metformin hydrochloride 1 gram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Empagliflozin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing only empagliflozin and linagliptin in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Empagliflozin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely empagliflozin 25 milligram and linagliptin 5 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Empagliflozin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely empagliflozin 25 milligram and linagliptin 5 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Empagliflozin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely empagliflozin 5 milligram and metformin hydrochloride 1 gram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Empagliflozin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely empagliflozin 5 milligram and metformin hydrochloride 1 gram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Empagliflozin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely empagliflozin 10 milligram and linagliptin 5 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Empagliflozin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely empagliflozin 10 milligram and linagliptin 5 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Empagliflozin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing empagliflozin and linagliptin in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Empagliflozin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Empagliflozin- and metformin-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Empagliflozin	Inferred relationship	Existential restriction modifier (core metadata concept)	2

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3010248012	Empagliflozin	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3010332013	Empagliflozin (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3010248012	Empagliflozin	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
3010248012	Empagliflozin	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3010332013	Empagliflozin (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
3010332013	Empagliflozin (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
56681000195112	empagliflozin	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
71711000195118	Empagliflozin	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
808381000172117	empagliflozine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
808381000172117	empagliflozine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
56681000195112	empagliflozin	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
71711000195118	Empagliflozin	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module